Company Oncolytics Biotech Inc. Nasdaq
Equities
CA6823101077
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Jon Patton
IRC | Investor Relations Contact | - | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
James Parsons
BRD | Director/Board Member | 58 | 22-06-15 |
Angela Holtham
BRD | Director/Board Member | 73 | 14-06-17 |
Wayne Pisano
CEO | Chief Executive Officer | 69 | 13-05-08 |
Deborah Brown
BRD | Director/Board Member | - | 17-11-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,310,671 | 73,369,775 ( 96.15 %) | 0 | 96.15 % |
Company contact information
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.com![address Oncolytics Biotech Inc.](https://cdn.zonebourse.com/static/address/10337.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |